Press Releases
Media Contact:
Amanda Ulrey
aulrey@iivs.org
301-947-6523
IIVS and Toxys Enter Into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation
March 9, 2023The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker® assay. ToxTracker is an innovative in vitroassay allowing identification of the genotoxic and potentially carcinogenic properties of novel and existing drugs, (agro)chemicals, cosmetics and other substances without the use of animal testing...
Experimental Toxicology and Ecology of BASF receives certification for Good In Vitro Method Practices
October 19, 2022Validation of the 3D RSMN Assay
February 10, 2021IIVS is excited to have taken part in the validation of the Reconstructed Skin Micronucleus Assay as a big step towards the establishment of an OECD test guideline. Read the Full Article Here
IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests
July 14, 2020The Institute for In Vitro Sciences (IIVS) has entered into an agreement with Shiseido and the Research Institute for Fragrance Materials (RIFM) to support the technology transfer of non-animal tests for photosafety testing. The program aims to build upon IIVS’ current photosafety tiered testing program, which addresses photoirritation, through the development of additional testing strategies to...
IIVS’ Outreach Program for Non-animal Test Methods Supported by Chinese Cosmetic Company
June 22, 2020June 23, 2020, Gaithersburg, MD - US based non-profit Institute for In Vitro Sciences Inc. (IIVS) has received its first funding from a Chinese owned and operated beauty tech company, Shenzhen Basixing Technology Co., Ltd. The occasion is significant as it demonstrates the growing desire for non-animal test methods in China and the importance of the IIVS program to help implement ...
IIVS Receives Support for Non-Animal Testing From RIFM
September 9, 2019September 10, 2019, Gaithersburg, MD – The Institute for In Vitro Sciences, Inc. (IIVS) is excited to announce that it has received a grant from the Research Institute for Fragrance Materials (RIFM) to support its mission to promote non-animal methods. The grant will be used to purchase equipment that will enable IIVS to expand capabilities and offer several non-animal tests in ...
PETA Science Group and Tobacco Companies Donate to Save Animals
August 28, 2019Donated Equipment Will Help to Replace Animals in Respiratory Toxicity Testing
Gaithersburg, MD — The PETA International Science Consortium Ltd., Imperial Brands PLC, Altria Client Services (ALCS), British American Tobacco PLC, and Philip Morris International Inc have joined together to donate equipment that can help to replace the use of animals in respiratory testing...IIVS and Partners Win Contract from the European Commission to Develop Training for Non-animal Testing Methods
July 16, 2019July 16, 2019, Gaithersburg, MD – The Institute for In Vitro Sciences (IIVS) is pleased to announce it is part of a winning consortium, headed by SYRCLE (the Systematic Review Centre for Laboratory animal Experimentation), to develop interactive eLearning training modules. The application of the Replacement, Reduction and Refinement of animal testing, commonly known as “The ...
European Partnership Supports IIVS Training of Chinese Scientists in Non-animal Tests
May 9, 2019Gaithersburg, MD – May 8, 2019 – The Institute for In Vitro Sciences, Inc. (IIVS) has received a grant from the European Partnership for Alternative Approaches to Animal Testing (EPAA) to support its annual ...
China’s Acceptance of Certain Non-Animal Testing Methods for the Regulation of Cosmetics
April 3, 2019Gaithersburg, MD – April 3, 2019 – The Institute for In Vitro Sciences (IIVS) applauds China’s National Medical Products Administration (NMPA) for their acceptance of certain non-animal (alternative) test methods for the regulation of cosmetics. In a notice issued on March 22, the NMPA drafted acceptance of nine test methods including: